To the Editor: The editorial by Coiera and Westbrook raises some important points.1 Appropriate models of governance (vis-à-vis regulation) surrounding clinical software are required if we are to drive innovative technology on a course that is safe and effective for patients.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.